These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 2927179

  • 1. Cytogenetic heterogeneity in erythroleukemia defined as M6 by the French-American-British (FAB) Cooperative Group criteria.
    Nakamura H.
    Leukemia; 1989 Apr; 3(4):305-9. PubMed ID: 2927179
    [Abstract] [Full Text] [Related]

  • 2. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study.
    Davey FR, Abraham N, Brunetto VL, MacCallum JM, Nelson DA, Ball ED, Griffin JD, Baer MR, Wurster-Hill D, Mayer RJ.
    Am J Hematol; 1995 May; 49(1):29-38. PubMed ID: 7741135
    [Abstract] [Full Text] [Related]

  • 3. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A, Larriba I, Rozman M, Irriguible D, Vallespí T, Aventin A, Ayats R, Millá F, Solé F, Florensa L, Gallart M, Tuset E, Lopez C, Woessner S.
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [Abstract] [Full Text] [Related]

  • 4. [Cytogenetic findings in acute myelogenous leukemias (FAB M 1 to M 6)].
    Prösch U, Stobbe H.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985 Feb; 112(4):481-94. PubMed ID: 2414178
    [Abstract] [Full Text] [Related]

  • 5. The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease.
    Goldberg SL, Noel P, Klumpp TR, Dewald GW.
    Am J Clin Oncol; 1998 Feb; 21(1):42-7. PubMed ID: 9499256
    [Abstract] [Full Text] [Related]

  • 6. De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19.
    Cigudosa JC, Odero MD, Calasanz MJ, Solé F, Salido M, Arranz E, Martínez-Ramirez A, Urioste M, Alvarez S, Cervera JV, MacGrogan D, Sanz MA, Nimer SD, Benitez J.
    Genes Chromosomes Cancer; 2003 Apr; 36(4):406-12. PubMed ID: 12619165
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Evolution to megakaryoblastic leukemia observed in myelodysplastic syndrome with erythrolekemia-like features].
    Takai K, Sanada M, Shibuya H.
    Rinsho Ketsueki; 1992 Aug; 33(8):1071-6. PubMed ID: 1404864
    [Abstract] [Full Text] [Related]

  • 9. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26).
    Fonatsch C, Gudat H, Lengfelder E, Wandt H, Silling-Engelhardt G, Ludwig WD, Thiel E, Freund M, Bodenstein H, Schwieder G.
    Leukemia; 1994 Aug; 8(8):1318-26. PubMed ID: 8057667
    [Abstract] [Full Text] [Related]

  • 10. Chromosome examinations on a six-hour culture of unstimulated peripheral blood from a patient with childhood erythroleukaemia.
    Selypes A, László A, Virág I.
    Haematologia (Budap); 1989 Aug; 22(1):19-24. PubMed ID: 2707646
    [Abstract] [Full Text] [Related]

  • 11. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
    Taniwaki M, Horiike S, Inazawa J, Nishida K, Misawa S, Takino T, Abe T.
    Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.
    Barnard DR, Alonzo TA, Gerbing RB, Lange B, Woods WG, Children's Oncology Group.
    Pediatr Blood Cancer; 2007 Jul; 49(1):17-22. PubMed ID: 16856158
    [Abstract] [Full Text] [Related]

  • 14. Cytogenetic and clinical assessment of six patients with erythroleukemia.
    Trent JM, Durie BG, Davis JR, Veomett I.
    Anticancer Res; 1983 Jul; 3(2):111-6. PubMed ID: 6573867
    [Abstract] [Full Text] [Related]

  • 15. High-resolution chromosomes as an independent prognostic indicator in adult acute nonlymphocytic leukemia.
    Yunis JJ, Brunning RD, Howe RB, Lobell M.
    N Engl J Med; 1984 Sep 27; 311(13):812-8. PubMed ID: 6472383
    [Abstract] [Full Text] [Related]

  • 16. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.
    Bernasconi P, Klersy C, Boni M, Cavigliano PM, Calatroni S, Giardini I, Rocca B, Zappatore R, Caresana M, Dambruoso I, Lazzarino M, Bernasconi C.
    Br J Haematol; 2007 May 27; 137(3):193-205. PubMed ID: 17408458
    [Abstract] [Full Text] [Related]

  • 17. Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease.
    Kasyan A, Medeiros LJ, Zuo Z, Santos FP, Ravandi-Kashani F, Miranda R, Vadhan-Raj S, Koeppen H, Bueso-Ramos CE.
    Mod Pathol; 2010 Aug 27; 23(8):1113-26. PubMed ID: 20473273
    [Abstract] [Full Text] [Related]

  • 18. Cytogenetic study of a case of childhood erythroleukemia.
    Duarte MH, Tone LG, Soares LR, dos Santos SA.
    Cancer Genet Cytogenet; 1990 Oct 01; 49(1):25-30. PubMed ID: 2397470
    [Abstract] [Full Text] [Related]

  • 19. Consecutive chromosomal studies in patients with myelodysplastic syndrome (MDS). Czechoslovak MDS Cooperative Group.
    Michalova K, Musilova J, Zemanova Z.
    Ann Genet; 1991 Oct 01; 34(3-4):212-8. PubMed ID: 1809229
    [Abstract] [Full Text] [Related]

  • 20. 5q-anomaly in a patient with erythroleukemia (M6-FAB classification).
    Donti E, Mecucci C, Rosetti A, Tabilio A, Venti G.
    Haematologica; 1985 Oct 01; 70(5):424-7. PubMed ID: 3937779
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.